Email UpdatesThis webinar is part of a series from the Opioid Response Network (ORN) and American Osteopathic Academy of Addiction Medicine (AOAAM) that takes a closer look at the initiation of buprenorphine in the age of fentanyl, managing opioid complexity in individuals with serious illness and the state of harm reduction in the US.
Description:
Dr. Kenneth Stoller, MD, will review a pilot study of pharmacy dispensing of methadone, the use of a secure pillbox for take home doses of methadone, and a survey of OTPs regarding extended take home doses of methadone during the COVID-19 pandemic. He will also review upcoming changes to Federal regulations for OTPs, and discuss how treatment access, quality, safety and patient-centeredness can be maintained and improved.
Learning Objectives:
At the end of the seminar learners will be able to:
- Identify at least two innovative ways to increase access to methadone treatment of opioid use disorder.
- Identify pros and cons to making methadone available through pharmacy prescribing.
- Learners will become familiar with the proposed regulatory changes to 42 CFR Part 8, issued in December 2022.